Navigation Links
International study finds lower-dose IUDs are safe and effective
Date:12/5/2013

LOS ANGELES (Dec. 5, 2013) In a finding that could expand the use of one of the most effective forms of birth control, two intrauterine contraceptive systems that had lower doses of the contraceptive hormone, levonorgestrel, were found to be safe and effective in preventing pregnancies, according to an international study that included researchers at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed).

The study, published in the December issue of the journal, Obstetrics & Gynecology, noted that the currently available higher-dose intrauterine contraceptive system has increased in popularity since its introduction in the U.S. in 2001 because of its safety, effectiveness and convenience: It doesn't require a woman to take a pill or take any specific actions immediately prior to intercourse.

But a recent survey found 60% of physicians rarely prescribe IUDs for women who have not borne children. In many European countries, they're only prescribed for women who have completed their families. Another recent study in U.S. family planning clinics found placement of the higher-dose intrauterine contraceptive systems failed in 19% of women who had not borne children.

The lower-dose intrauterine contraceptive systems are smaller than the higher-dose systems and, the study found, they are easier to use in women who have not delivered a child or have delivered only by cesarean section. Researchers at 138 centers across 11 countries tested the devices in nearly 3,000 women and rated placement of the smaller devices as "easy" in 90% of the women.

"By demonstrating the safety and efficacy of low-dose intrauterine contraceptive devices, this study will help expand the contraceptive options available to women who have not had children before," said Anita Nelson, MD, an LA BioMed lead researcher and corresponding author of the study. "Additionally, a lower dose system may be preferable to women who are seeking to reduce their exposure to synthetic hormones."

The study tested two intrauterine contraceptive systems: one with 13.5 milligrams of levonorgestrel and another with 19.5 milligrams. It found both to be highly effective and well-tolerated over a three-year period. The currently available higher-dose intrauterine contraceptive system has 52 milligrams of levonorgestrel.


'/>"/>

Contact: Laura Mecoy
310-546-5860
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)
Source:Eurekalert

Related medicine news :

1. International breast health global summit will focus on supportive care and quality of life
2. International conference to explore health of descendants of transatlantic slave trade
3. Kessler Foundation researchers present at first International Congress on Cognition in MS
4. Internationally known expert in ovarian cancer to be honored at the ASCO Annual Meeting
5. Nobel laureate to keynote international pharmaceutical conference at URI
6. International Nanomedicine Conference bound for Sydney: July 2-4, 2012
7. June 2012 marks a milestone for International Urogynecology Associates as Dr. Robert D. Moore and Dr. John R. Miklos perform their 24th Neovagina Surgery in 24 months
8. Heavy Duty Alternators and Starters Expert Elreg Distributors Ltd. Meets Needs of International Market with Launch of Spanish Website
9. The US Drug Watchdog Now Urges Plaintiffs Law Firms Worldwide To Contact Them About A Possible International Effort To Help Victims Of Defective Drugs Or Medical Devices
10. RMAX International to donate Recuper8 - a free, health - restoring program to Everyone in Uniform
11. International symposium on veterinary rehabilitation and physical therapy to be held in Vienna
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... ... ... Recognizing that lifestyle medicine is essential to health and healthcare, About.com ... MD, MPH, president of the American College of Lifestyle Medicine, as their first senior ... said Katz. “There is so much opportunity to add years to lives, and life ...
(Date:5/4/2016)... Carlsbad, CA (PRWEB) , ... May 04, 2016 , ... ... has recently partnered with local company MitoXcell in preparation of the launch of her ... day jump start plan is a nutritional guide designed to jump start a new ...
(Date:5/4/2016)... , ... May 04, 2016 , ... The preeminent surgical ... Janice Dickinson needed following breast cancer surgery. In March 2016, the 61-year-old model and ... of breast cancer that occurs in the milk ducts, according to an interview ...
(Date:5/4/2016)... CA (PRWEB) , ... May 04, 2016 , ... Advanced ... technology to help restore its patients’ health, is hosting a free seminar on stem ... will be held at Advanced Spine & Sport, 4601 Telephone Road, Suite 110, Ventura, ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... ankles, and elbows. Engineered with athletes in mind, OMNIFORCE offers high-performance, less ... ineffective circular knitting, common in the industry) produces premium flat-knit construction with ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... Research and Markets has announced the addition ... Outlook 2020" report to their offering. ... has improved significantly in past years due to which ... years. Many cancer drugs have been developed by utilization ... expected to be developed with its help. They are ...
(Date:5/3/2016)...  While you may be familiar with watching a film or TV show in high definition, ... 8MP in the Medical Industry.  Ampronix  is a renowned authorized reseller of the medical industry,s ... - http://photos.prnewswire.com/prnh/20160502/362730 ... ... ...
(Date:5/3/2016)... 3, 2016  Specialty Silicone Fabricators is offering ... how a cleanroom works. The free visual aid ... and technology. Chris Mazelin ... company, SSF enthusiastically supports the Science, Technology, Engineering ... the next generation of innovators. We want to ...
Breaking Medicine Technology: